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doi:10.1016/j.ejvs.2008.05.005Abstract Background: This study aimed to review the literature regarding fracture of arterial
stents, especially its relation to location of placement, clinical relevance, and type of stents.
Material and methods: We searched published articles in PubMed up to February 2008 by using
the terms: stent fracture or stent breakage.
Results: Thirty-one articles met our inclusion and exclusion criteria. Most of the studies
reported fractures in stents placed in the superficial femoral artery or popliteal arteries.
The cumulative incidence of stent fractures ranged from 2% to 65%, i.e. 0.6 to 60 per 1000 per-
son-months. Stent fractures occur more frequently in the superficial femoral artery and are
common when multiple stents are deployed and overlap. Stent fractures are associated with
a higher risk of inestent restenosis and re-occlusion.
Conclusion: The incidence of stent fracture, its location of placement, and type of stent used
were diverse across studies. Stent fracture may cause clinical deterioration especially in the
femoropopliteal segment, and it should be detected before clinical manifestation appears.
Further studies with larger study population involving new type of stents for a longer follow
up period are warranted.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Department of Vascular Sur-
Hospital, Pilsonu Street 13,
0 20 66.
its).
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Intravascular stents are frequently used to treat stenoses or
occlusive disease in the vascular system. Percutaneous
arterial therapy was developed in 1969 after Charles Dotter
described the original technique.1 In 1985, Palmaz reportedd by Elsevier Ltd. All rights reserved.
340 J. Rits et al.results of stent placement in dog arteries.2 The first stent
was implanted into a human coronary artery in 1986.3
Currently commercially available stents canbydivided into
three major types: ballooneexpandable, selfeexpanding,
and shape-memory or nitinol stents. Since first clinical
application of stents, many technical improvements have
been developed. The technical parameters of the device, e.g.
the rigidity, strength, elasticity andplasticity, should be taken
intoaccountwhenplacing stents atparticular vascular sites. It
is still disputed whether primary stenting is necessary or if
stenting should only be performed after an unsuccessful
angioplasty.4e12 Initial technical success rates are high for
arterial stents, however, the durability of these devices in
different peripheral vascular beds is diverse. Complications
can arise, and stent fracture is one example. Stent fractures
may cause a number of complications, such as restenosis,
occlusion, pseudo-aneurysm, vessel perforation, and embo-




We searched the published literatures in PubMed up to
February 2008 by using the searching terms stent fracture
or stent breakage. Our inclusion criteria were that a full
original study was published in English, Dutch or German,
and that the authors reported stent fracture in stenotic or
occluded peripheral arteries. Articles reporting stent frac-
tures in either aorta or coronary arteries, non-arterial
settings and patency of stent grafts were excluded. Manual
cross-check from the reference lists of all relevant articles
identified additional papers, which were not found in
Pubmed by our searching term.
Results
We initially identified 346 articles related to stent fracture in
Pubmed. After assessing those studies and related articles
from manual cross-check, 31 articles met our inclusion
criteria, and were included in our review.4e8,13e38 Most of
the studies reported stent fractures in the femoropopliteal
or superficial femoral artery segment. The baseline character-
istics of the articles are presented in Table 1. The study design
of the articles was heterogeneous. Six studies were performed
in a prospective manner6,27e31; five studies27e31 were random-
ized, whereas some of them were extension from the previous
studies.29,31 Nine studies were performed in a retrospective
manner,7,8,14,15,17,21,23,24,32 seventeen were case repor-
ts.4,5,13,16,18e20,22,25,26,33e38 We found articles related to stent
fractures in the tibioperional trunk,4 popliteal artery,5,13,33
femoropopliteal,6,7 superficial femoral artery,8,14,15,28e33
iliac,16,17,34 renal,18e21,35 superior mesenteric artery,36 bra-
chiocephalic trunk,37 subclavian,22 vertebral arteries,23,24,38
carotid artery,25 and pulmonary artery.27
Incidence
Table 2 presents the incidence of stent fractures. The
cumulative incidence (frequency of stent fractures) rangedfrom 2% to 65%. This incidence rate is equivalent to 0.6e60/
1000 person-months (Table 2). Scheinert et al.6 investi-
gated the occurrence and clinical impact of nitinol stent
fracture after femoropoliteal stenting. By examining 121
legs after femoropopliteal artery stenting with a mean fol-
low up of 10.7 months, they found that 37% (45/121) of legs
treated had 64 stent fractures. Sabety et al.7 reported 8
(15%) stent fractures in the femoropopliteal segment of
53 treated legs after 8 months follow-up. Iida et al.8 re-
ported data of superficial artery stenting with nitinol stents
in 40 examined patients after mean follow-up of 13.6
months. Stent fractures occurred in 28% (11/40) of pa-
tients. They found that the incidence of stent fracture for
patients who walked >5000 steps/day was higher than
patients who did not. Duda et al.27 reported results of
a prospective study evaluating the effectiveness of shape
memory alloy recoverable technology (SMART) nitinol self-
expending stents coated with a polymer impregnated with
serolimus (rapamicin) versus uncoated SMART stents in
superficial femoral artery obstructions. The mean length
of stented segment was 85 mm and the rate of nitinol stent
fractures was 18% (6/33) after 6 months. Duda et al.28 re-
ported a series of stents placed in the superficial femoral
artery. The mean length of stented segment was 81.5 mm
and after 6 months the incidence of stent fractures was
8% (4/50). Subsequently the same authors29 reported an in-
cidence of stent fractures of 26% (17/65). Schlager et al.14
compared stent fractures in nitinol stents versus Wallstents
implanting for sub-optimal angioplasty in the superficial
femoral artery. Radiographically, 11% (25/220) of the
patients had stent fractures. Allie et al.15 reported a 65%
incidence of stent fractures in 110 patients treated with
nitinol stents at 11 months. Ferreira et al.32 reported one
class II fracture (multiple single struts at different loca-
tions) using nitinol stents (Zilver, Cook, USA) in 59 treated
patients after mean follow-up of 2.4 years. Schilinger
et al.31 reported 2 stent fractures after 12 month and there
were no new stent fractures after 24 month for the same
group of patients.
There were two case reports16,34 and one retrospective
study17 regarding stent fractures in the iliac artery.
Müller e Leise et al.17 reported data of 23 patients with
a mean length of iliac artery occlusion of 12 cm. One of 3
stented patients had early re-occlusion due to stent break-
age. There were four case reports of renal artery stenting
and stent fracture afterwards.18e20,34 One clinical study
described renal artery entrapment by the diaphragmatic
crus. There was only one stent fracture in three stented
patients.21 Klepczyk et al.36 presented two cases of frac-
ture following stenting of the superior mesenteric artery.
Periard et al.37 described clinically significant stent rupture
in the brachiocephalic trunk causing vertebral steal syn-
drome. One case report22 described 3 cases of stent frac-
ture in the subclavian artery and two cases of stent
breakage in the subclavian vein. In 12 patients with symp-
tomatic ostial vertebral artery stenosis who underwent
stent implantation, Tsutsumi et al.23 reported 3 stent frac-
tures during a mean follow up of 31.5 months. Weber
et al.24 reported 2 stent fractures out of 26 patients with
symptomatic atherosclerotic stenosis in the proximal verte-
bral artery treated with flexible balloon expandable stents
after a mean followeup of 11 months.
Table 2 Incidence of stent fractures
No Author/year Vascular bed No of Tx No of # CI of # (%) Follow-up IR (/1,000)
Mean (m) Total (pm)
1 Scheinert D, 2005 FPA 121 45 37 11 1.295 35
2 Sabety S, 2005 FPA 53 8 15 8 424 19
3 Iida O, 2006 SFA 40 11 28 14 544 20
4 Duda SH, 2002 SFA 33 6 18 6 198 30
5 Duda SH, 2005 SFA 50 4 8 6 300 13
6 Duda SH, 2006 SFA 65 17 26 18 1.170 15
7 Schlager O, 2005 SFA 220 25 11 29 6.380 4
8 Allie DE, 2004 SFA 110 72 65 11 1.210 60
9 Ferreira M, 2007 SFA 59 1 2 29 1711 0.6
10 Schillinger M, 2006 SFA 51 2 4 12 612 3
11 Schilinger M, 2007 SFA 46 2 4 24 1104 2
12 Müller-Leisse C, 2001 IA 3 1 33 ? ? ?
13 Thony F, 2005 RA 3 1 33 24 72 14
14 Tsutsumi M, 2006 VA 12 3 25 32 378 8
15 Weber W, 2005 VA 26 2 8 11 286 7
FPA Z femoropopliteal artery, SFA Z superficial femoral artery, IA Z iliac artery, RA Z renal artery, VA Z vertebral artery, CI Z cumu-
lative incidence, IR Z incidence rate, m Z months, pm Z person-months, Tx Z treatment, # Z fracture.
Table 1 Baseline characteristics of the articles
No Author Year Type of study No of cases Vascular bed
1 Schwarzmaier - D’Assie4 2007 Case report 1 Tibioperioneal trunk
2 Furuichi S33 2007 Case report 1 Popliteal artery
3 Solis J5 2006 Case report 1 Popliteal artery
4 Babalik E13 2003 Case report 1 Popliteal artery
5 Scheinert D6 2005 Prospective cohort 121 Femoropopliteal
6 Sabety S7 2005 Retrospective cohort 65 Femoropopliteal
7 Iida O8 2006 Retrospective cohort 40 SFA
8 Duda SH27 2002 Randomized, multicenter, double-blind 36 SFA
9 Duda SH28 2005 Randomized, multicenter, double-blind 57 SFA
10 Duda SH29 2006 Randomized, multicenter, double-blind 93 SFA
11 Schlager O14 2005 Retrospective cohort 220 SFA
12 Allie DE15 2004 Retrospective cohort 110 SFA
13 Ferreira M32 2007 Retrospective cohort 59 SFA
14 Schillinger M30 2006 Randomized, single-institution 51 SFA
15 Schillinger M31 2007 Randomised, single-institution 46 SFA
16 Higashiura W34 2008 Case report 1 Iliac artery
17 Sacks BA16 1996 Case report 1 Iliac artery
18 Muller e Leisse C17 2001 Retrospective cohort 23 Iliac artery
19 Robertson SW35 2008 Case report 1 Renal artery
20 Sahins S18 2005 Case report 1 Renal artery
21 Bessias N19 2005 Case report 1 Renal artery
22 Bauget JP20 2003 Case report 1 Renal artery
23 Thony E21 2005 Retrospective cohort 3 Renal artery
24 Klepczyk L36 2008 Case report 2 SMA
25 Periard D37 2008 Case report 1 BCT
26 Phipp LH22 1999 Case report 3 Subclavian artery & vein
27 KIM SR38 2007 Case report 2 Vertebral artery
28 Tsutsumi M23 2006 Retrospective cohort 12 Vertebral artery
29 Weber W24 2005 Retrospective cohort 26 Vertebral artery
30 Valibhoy AR25 2007 Case report 1 Carotid artery
31 Knirsch W26 2003 Case report 1 Pulmonary artery
SFA Z superficial femoral artery, SMA Z superior mesenteric artery, BCT Z brachiocephalic trunck.
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342 J. Rits et al.Valibhoy et al.25 presented a case of stent fracture using
a selfeexpanding stent in a patient who underwent carotid
artery stenting for stenosis. Knirsch et al.26 presented the
only case report about longitudinal stent fracture 11
months after implantation in the left pulmonary artery.
Clinical relevance
Table 3 presents the clinical implication of stent fracture.
Scheinert et al.6 reported 64 stent fractures in 45 treated
legs after 11 months. 67% of 64 stent fractures in the fem-
oropopliteal segment were associated with stent occlusion
or restenosis, and concluded that there was a considerable
risk of stent fractures after long segment femoral artery
stenting, which is associated with a higher in-stent resteno-
sis and re-occlusion. Sabety et al.7 reported 8 stent frac-
tures in the femoropopliteal segment of 53 treated legs
after 8 months. Restenosis was found in 75% (6/8) of cases.
They found that mid-term restenosis after long-segment
femoropopliteal stenting using nitinol stents remained
a major problem, particularly in patients with diabetes
mellitus. However, mid-term results in nondiabetic patients
were encouraging. Duda et al.27 reported results of a pro-
spective study where all 6 (18%) nitinol stent fractures after
6 months were asymptomatic. In a subsequent study,28 they
reported 8% (4/50) stent fractures without symptom after 6
months. Later on, Duda et al.29 extended both previous
studies27,28 with follow-up up to 18 months. They did not
find any clinical symptoms in patients with stent fracture.
Schlager et al.14 demonstrated that the length of the
stented segment was significantly associated with stent
fractures (p Z 0.046). In patients with Wallstents (Boston
Scientific, Natik, MA, USA), they did not find significant as-
sociation between fractures and restenosis (p Z 0.56);
whereas in patients with SMART stents (Cordis, Miami, Flor-
ida, USA), fractures were significantly associated with
restenosis (p Z 0.008). No complications other than reste-
nosis were associated with stent fractures in this study.Table 3 Clinical implication of stent fracture
No Author/year Vascular bed No of # No of C
1 Scheinert D, 2005 FPA 64 43
2 Sabety S, 2005 FPA 8 6
3 Iida O, 2006 SFA 11 ?
4 Duda SH, 2002 SFA 6 0
5 Duda SH, 2005 SFA 4 0
6 Duda SH, 2006 SFA 17 0
7 Schlager O, 2005 SFA 25 ?
8 Allie DE, 2004 SFA 72 55
9 Ferreira M, 2007 SFA 1 ?
10 Schillinger M 2006 SFA 2 ?
11 Schilinger M 2007 SFA 2 ?
12 Muller - Leisse C 2006 IA 1 1
13 Thony F, 2005 RA 1 1
14 Tsutsumi M, 2006 VA 3 0
15 Weber W, 2005 VA 2 0
FPA Z femoropopliteal artery, SFA Z superficial femoral artery, IA Z il
Co Z complications, (m) Z month, SS Z stented segment.Unfortunately they did not report the number of patients
with restenosis due to stent fracture. Allie et al.15 found
that stent fractures were associated with angiographic ste-
nosis (>50%) or occlusion in 76% (55/72) patients, where
60% (33/55) patients were clinically symptomatic. In this
study, the average lesion length was 17.5 cm (range: 6e
34 cm). Significant clinical implications of stent fracture
were not clearly mentioned in some studies.30e32 Müller e
Leise et al.17 reported one early re-occlusion of 3 stented
iliac arteries due to stent breakage. Thony et al.21 reported
one renal artery restenosis due to stent fracture 24 months
after deployment. Tsutsumi et al.23 reported 25% (3/12)
asymptomatic stent fractures after a mean follow up of
32 months. Weber et al.24 reported 8% (2/26) asymptomatic
stent fractures after a mean followeup time of 11 months.
The overall mean follow-up time of the studies included
in our review ranged from 6 to 32 months. Clinical
complications were more frequently found in studies with
longer follow up time (Table 3).
Type of stent
Table 4 shows the type of stent used in different vascular
beds. Scheinert et al.6 analyzed the performance of differ-
ent nitinol stents. They reported fracture rates of 27% (14/
52) for SMART, 29% (7/24) for SelfX (Abbot Medical Devices,
Beringen, Switzerland), and 53% (24/45) for Luminex
(BARD, Murray Hill, New Jersey). There were no initial
differences between groups. Iida et al.8 reported 28%
(11/40) stent fractures using Luminex stents in the superfi-
cial femoral artery. In patients with stent fractures, the
lesion length was longer (215 vs. 114 mm) and the number
of stents used per case was greater (2.4 vs. 1.4). Duda
et al.27 reported 3 nitinol stent fractures in SMART seroli-
mus eluting and 3 nitinol stent fractures in the uncoated
SMART group. In 2005, Duda et al.28 reported 2 nitinol stent
fractures in SMART serolimus eluting (Cordis, Miami, FL,





11 157 67.2% occlusion or retenosis
8 160 75% restenosis
14 215 ?%
6 85 no restenosis
6 82 no restenosis
18 83 no restenosis
29 107/139/125 ?% restenosis




? 120 1 of 1 reocclusion
24 ? 1 of 1 restenosis
32 ? no restenosis
11 ? no restenosis
iac artery, RA Z renal artery, VA Z vertebral artery, # Z fracture,
Table 4 Type of stents
No Author/year Vascular bed Mean length SS (mm) Type of stent
1 Scheinert D, 2005 FPA 157 SMART SelfiX Luminex
2 Sabety S, 2005 FPA 160 SMART Dynalink
3 Iida O, 2006 SFA 215 Luminexx
4 Duda SH, 2002 SFA 85 SMART (se) SMART (b)
5 Duda SH, 2005 SFA 82 SMART (se) SMART (b)
6 Duda SH, 2006 SFA 83 SMART (se) SMART (b)
7 Schlager O, 2005 SFA 107/139/125 Wallstent SMART Dynalink/Absolute
8 Allie DE, 2004 SFA 175 Nitinol stents?
9 Ferreira M, 2007 SFA 192 Zilver
10 Schillinger M, 2006 SFA 132 Dynalink Absolute
11 Schilinger M, 2007 SFA 132 Dynalink Absolute
12 Muller - Leisse C, 2006 IA 120 Palmaz
13 Thony F, 2005 RA ? Wallstent
14 Tsutsumi M, 2006 VA ? Palmaz Bx Velocity S670 Driver
15 Weber W, 2005 VA ? S670 Velocity
FPA Z femoropopliteal artery, SFA Z superficial femoral artery, IA Z iliac artery, RA Z renal artery, VA Z vertebral artery, SS Z stented
segment, (se) Z serolimus eluting, (b) Z bare.
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sults from both previous studies27,28 up to 18 month and
found 8 stent fractures in the bare stent group and 9 stent
fractures in the serolimus eluting stent. Schlager et al.14
reported 11% (25/220) stent fractures in the superficial
femoral artery. The fracture rates were 19% (15/78) for
Wallstent after a mean followeup of 43 months (mean
stented lesion length 107 71 mm), 28% (8/29) for SMART
stents after a mean follow-up of 32 16 months (mean
stented lesion length 139 88 mm), and 2% (2/113) for
Dynalin/Absolute stents after a mean follow-up of 15
months (mean stented lesion length 125 84 mm). Allie
et al.15 reported 65% stent fractures. However, they did
not describe what types of nitinol stents were used. Recent
studies indicated that the occurrence of nitinol stent frac-
tures are low in mid- to long-term follow-up.30e32
A wallstent (6 28 mm, Boston Scientific, Galway,
Ireland) was used to treat renal artery stenosis due to
entrapment by the diaphragmatic crus. Stent fracture was
detected two years after deployment.21 Weber et al.24 re-
ported 2 stent fractures in 26 patients with symptomatic
atherosclerotic stenoses in the proximal vertebral artery
treated with flexible balloon expandable stents S670 or
Velocity (Cordis, Miami Lakes, FL, USA); however, type of
stent was not described.Discussion
This review has identified great differences in the reported
cumulative incidence of stent fractures. For example, the
range of reported stent fracture in the superficial femoral
artery is 2 to 65% (Table 2). Fracture was more commonly
reported in studies specifically looking for stent frac-
tures.6,8,14,15 Stent fractures occur mostly in the bending
vascular segments close to joints such as femoropopliteal
and femoral segments.4e8,13e15,28e33 From 31 articles re-
viewed, 15 were cohort and randomized studies. 73% (11/
15) of the studies were reflecting stent fractures in the
femoropopliteal or superficial femoral artery (SFA). Ourreview reveals that stent fractures occur more frequently
after long segment femoral artery stenting, which is associ-
ated with a higher inestent restenosis and reocclusion
rates. A recent clinical trial (RESILIENT trial) reports no ni-
tinol stent fracture in the SFA and popliteal segment after
12 month of follow up.39 Stent fractures are more common
with multiple stent deployment and overlap.6e8,13e15 Only
one paper reported the risk factors influencing nitinol stent
fractures in the SFA, and walking habits was associated with
stent fracture.8 Unfortunately, the study had exclusively
used stents with high potential of fracture (Luminexx,
BARD, Murray Hill, New Jersey). However, we found that
the number of patients with stent fractures was reported
differently, and the correct incidence was unclear.
When stent fracture occurs, it commonly correlates with
restenosis or re-occlusion in the stented artery and causes
decline of clinical condition.6e8,14,15,21,23,24,27e32
We assessed stent fractures in relation to stent design.
Only one study14 compared stent fractures in nitinol stents
versus Wallstents, implanted for sub-optimal angioplasty
in the SFA. The incidence of stent fracture was lower in
Dinalink/Absolute stents. However differences in length
of targeted vessels (length of stent), number of stents
used, type of stent, and follow-up time make conclusions
difficult.6,14,27e31 In other studies,9e12 Palmaz and Abso-
lute stent fractures were not demonstrated in the SFA.
Schilinger et al.30e32 reported low occurrence of stent
fracture in the SFA despite multiple nitinol stent deploy-
ment after mid- to long-term follow-up.
Stainless steel stent fractures were reported in other
vascular beds such as renal21 and vertebral23,24 arteries. We
found single case reports regarding stent fractures in the sub-
clavian artery,22 brachiocephalic trunk,37 carotid artery,25
and superior mesenteric artery.36
Stent fractures in the vertebral artery segments occurred
in balloon-expandable, coronary stainless steel stents, and
were not associated with clinical adverse events.23,24 For in-
cidence calculation, we included only 15 studies (cohort and
randomizes studies). There were 217 stent fractures in 850
procedures, giving an average cumulative incidence of stent
344 J. Rits et al.fractures of 26%. Approximately half of these patients had
restenosis or occlusion of the stented segment. Mean fol-
low-up time ranged from 6 to 32 months. Possibly more stent
fractures might be detected if the follow-up time was lon-
ger, and studies were performed with the aim of searching
for stent fractures by using X-ray and ultrasound screening.
Ideally all diagnostic images should be analyzed and magni-
fied if stent fracture is suspected.40
In conclusion, the incidence of stent fracture, its
location of placement, and type of stent used were diverse
across studies. If stent fracture occurs, it causes clinical
deterioration especially in the femoropopliteal segment.
Therefore, stent fracture should be detected before clin-
ical manifestation appear. The implantation of stents
should be well considered. Further studies with larger study
population involving new type of stent for a longer follow
up period are warranted.References
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